Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04213794
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:49.562832+00:00
Published At
2025-02-20T00:00:00+00:00
Record Updated At
2025-02-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Malignant Abdominal Neoplasm", "Malignant Pelvic Neoplasm", "Recurrent Colon Carcinoma", "Recurrent Desmoplastic Small Round Cell Tumor", "Recurrent Fallopian Tube Carcinoma", "Recurrent Gastric Carcinoma", "Recurrent Liposarcoma", "Recurrent Malignant Mesothelioma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma", "Recurrent Rectal Carcinoma", "Recurrent Rhabdomyosarcoma", "Recurrent Sarcoma", "Refractory Colon Carcinoma", "Refractory Desmoplastic Small Round Cell Tumor", "Refractory Fallopian Tube Carcinoma", "Refractory Gastric Carcinoma", "Refractory Liposarcoma", "Refractory Malignant Mesothelioma", "Refractory Ovarian Carcinoma", "Refractory Primary Peritoneal Carcinoma", "Refractory Rectal Carcinoma", "Refractory Rhabdomyosarcoma", "Refractory Sarcoma", "Resectable Liposarcoma", "Resectable Malignant Mesothelioma", "Resectable Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-20"
protocolSection.identificationModule.nctId
"NCT04213794"
protocolSection.identificationModule.officialTitle
"A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Malignant Abdominal Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Pelvic Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Colon Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Desmoplastic Small Round Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Gastric Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Liposarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Mesothelioma (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Rectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Sarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Colon Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Desmoplastic Small Round Cell Tumor (protocolSection.conditionsModule.conditions)
  • Refractory Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Gastric Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Liposarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Malignant Mesothelioma (protocolSection.conditionsModule.conditions)
  • Refractory Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Rectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Refractory Sarcoma (protocolSection.conditionsModule.conditions)
  • Resectable Liposarcoma (protocolSection.conditionsModule.conditions)
  • Resectable Malignant Mesothelioma (protocolSection.conditionsModule.conditions)
  • Resectable Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.